Pharmacokinetics, Exposure-Response Relationships, and Immunogenicity in Crohn's Disease Patients With Ustekinumab Secondary Loss of Response Following Ustekinumab IV Re-Induction: Week 16 Results From the POWER Study

被引：0

作者：

Feagan, Brian G. ^{[1
]}

Lee, Scott D. ^{[2
]}

van der Woude, C. Janneke ^{[3
]}

Marin-Jimenez, Ignacio ^{[4
]}

Wolf, Douglas C. ^{[5
]}

Schnoy, Elisabeth ^{[6
]}

Salzberg, Bruce ^{[7
]}

Busse, Christopher ^{[8
]}

Nazar, Maciej ^{[9
]}

Langholff, Wayne ^{[10
]}

Gasink, Christopher ^{[8
]}

Baker, Thomas ^{[10
]}

Godwin, Bridget ^{[8
]}

Adedokun, Omoniyi ^{[10
]}

Schreiber, Stefan ^{[11
]}

机构：

[1] Western Univ, London, ON, Canada

[2] Univ Washington, Seattle, WA USA

[3] Erasmus Univ, Med Ctr, Rotterdam, Netherlands

[4] Hosp Univ Gregorio Maranon, IiSGM, Rotterdam, Zuid Holland, Netherlands

[5] Atlanta Gastroenterol Associates, Atlanta, GA USA

[6] Univ Hosp Augsburg, Augsburg, Germany

[7] IBD Ctr Atlanta, Atlanta Gastroenterol, Atlanta, GA USA

[8] Janssen Sci Affairs LLC, Horsham, PA USA

[9] Janssen Cilag Polska Sp Zoo, Warsaw, Poland

[10] Janssen Res & Dev LLC, Spring House, PA USA

[11] Univ Hosp Schleswig Holstein, Kiel, Germany

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S842

引用

页码：S622 / S622

页数：1

共 50 条

[1] Efficacy and safety of intravenous ustekinumab re-induction therapy in Crohn's disease patients with secondary loss of response to ustekinumab maintenance therapy: Week 16 results from the POWER trial
Schreiber, S. W.
Lee, S.
Van der Woude, C. J.
Marin-Jimenez, I.
Wolf, D.
Schnoy, E.
Salzberg, B.
Busse, C.
Nazar, M.
Langholff, W.
Borghorst, S.
Gasink, C.
Baker, T.
Godwin, B.
Feagan, B.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 564 - 564
[2] EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB RE-INDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER TRIAL
Lee, Scott D.
Schreiber, Stefan
Janneke, Christien
Van der Woude
Marin-Jimenez, Ignacio
Wolf, Douglas C.
Schnoy, Elisabeth
Salzberg, Bruce
Busse, Christopher
Nazar, Maciej
Langholff, Wayne
Borghorst, Stephan
Gasink, Christopher
Baker, Thomas
Godwin, Bridget
Feagan, Brian G.
GASTROENTEROLOGY, 2023, 164 (06) : S220 - S220
[3] PHARMACOKINETICS, IMMUNOGENICITY, AND EXPOSURE-RESPONSE RELATIONSHIP OF USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE WEEK 16 INTERIM ANALYSIS OF THE STARDUST STUDY
D'Haens, Geert R.
Adedokun, Omoniyi J.
Danese, Silvio
Vermeire, Severine
Panes, Julian
Dignass, Axel
Magro, Fernando
Nazar, Maciej
Le Bars, Manuela
Lahaye, Marjolein
Ni, Lioudmila
Gaya, Daniel R.
Peyrin-Biroulet, Laurent
GASTROENTEROLOGY, 2021, 160 (06) : S694 - S694
[4] Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy
Bermejo, Fernando
Jimenez, Laura
Algaba, Alicia
Vela, Milagros
Bastida, Guillermo
Merino, Olga
Lopez-Garcia, Alicia
Melcarne, Luigi
Rodriguez-Lago, Iago
de la Maza, Saioa
Bouhmidi, Abdel
Barreiro-de Acosta, Manuel
Lopez-Serrano, Pilar
Carrillo-Palau, Marta
Mesonero, Francisco
Orts, Beatriz
Bonillo, Daniel
Granja, Alicia
Guerra, Ivan
INFLAMMATORY BOWEL DISEASES, 2022, 28 (01) : 41 - 47
[5] EFFICACY OF INTRAVENOUS USTEKINUMAB RE-INDUCTION IN PATIENTS WITH CROHN'S DISEASE WITH A LOSS OF RESPONSE
Heron, Valerie
Panaccione, Nicola
Candido, Kristina
Bessissow, Talat
Bitton, Alain
Seow, Cynthia H.
Panaccione, Remo
Afif, Waqqas
GASTROENTEROLOGY, 2019, 156 (06) : S877 - S877
[6] Efficacy of intravenous ustekinumab re-induction in patients with Crohn's disease with a loss of response
Heron, V.
Panaccione, N.
Candido, K.
Bessissow, T.
Bitton, A.
Seow, C.
Panaccione, R.
Afif, W.
JOURNAL OF CROHNS & COLITIS, 2019, 13 : S347 - S348
[7] Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease
Adedokun, Omoniyi J.
Xu, Zhenhua
Gasink, Christopher
Jacobstein, Douglas
Szapary, Philippe
Johanns, Jewel
Gao, Long-Long
Davis, Hugh M.
Hanauer, Stephen B.
Feagan, Brian G.
Ghosh, Subrata
Sandborn, William J.
GASTROENTEROLOGY, 2018, 154 (06) : 1660 - 1671
[8] Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn's disease
Huinink, Sebastiaan ten Bokkel
Biemans, Vince
Duijvestein, Marjolijn
Pierik, Marieke
Hoentjen, Frank
West, Rachel L.
van der Woude, Christien J.
de Vries, Annemarie C.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E783 - E788
[9] Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn's disease
Huinink, Sebastiaan ten Bokkel
Biemans, Vince
Duijvestein, Marjolijn
Pierik, Marieke
Hoentjen, Frank
West, Rachel L.
van der Woude, Christien J.
de Vries, Annemarie C.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E783 - E788
[10] Analysis of Baseline Characteristics Associated With Clinical Response to Ustekinumab IV Re-Induction Strategy in Patients With Crohn's Disease in the POWER Trial
Wolf, Douglas C.
Lee, Scott D.
Schreiber, Stefan
van der Woude, C. Janneke
Marin-Jimenez, Ignacio
Schnoy, Elisabeth
Salzberg, Bruce
Busse, Christopher
Nazar, Maciej
Langholff, Wayne
Gasink, Christopher
Baker, Thomas
Godwin, Bridget
Feagan, Brian G.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S786 - S786

← 1 2 3 4 5 →